Valrubicin is an anthracycline chemotherapy drug infused directly into the bladder (intravesical therapy). It is mainly used to treat Bacillus Calmette-Guérin (BCG)-refractory carcinoma in situ of the bladder in patients who cannot undergo or refuse surgical removal (cystectomy). It is grouped under the following drug class(es): Anthracyclines, Antineoplastic agents, Cytotoxics and Topoisomerase inhibitors. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Valtaxin and Valstar Preservative Free. Its PubChem CID is 454216.
Valrubicin
| CAS No | 56124-62-0 |
|---|---|
| Molecular Formula | C34H36F3NO13 |
| Molecular Weight | 723.6 g/mol |
| Synonyms | [2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Valrubicin is an anthracycline chemotherapy drug infused directly into the bladder (intravesical therapy). It is mainly used to treat Bacillus Calmette-Guérin (BCG)-refractory carcinoma in situ of the bladder in patients who cannot undergo or refuse surgical removal (cystectomy).
The listed CAS number is 56124-62-0.
The listed molecular formula is C34H36F3NO13.
The listed molecular weight is 723.6 g/mol.
[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate.
The source lists Valtaxin and Valstar Preservative Free.